The nation of Zimbabwe has declined a major American healthcare agreement worth $367m (272 million pounds) spanning five years because of the United States' demand for sensitive data.
The decision became public after a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "lopsided".
An official representative has since explained that the US was requesting biological samples for scientific study and profit but was not willing to share the resulting advantages from future treatments.
"We are forced to start the difficult and regrettable process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for more talks to find a deal acceptable to all parties so the nation's vital HIV treatment initiative can continue.
Broader Background
Zimbabwe's decision follows a similar situation in Kenya, where a high court halted a similar deal with the US following legal challenges were raised about the safety of citizens' medical information.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral deals to enhance transparency and responsibility.
According to reports, 16 African countries have so far signed similar health pacts, constituting over $18.3bn in new funding.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to provide its biological resources and data for a long time, without any equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," he stated.
"In essence, our nation would supply the raw materials for scientific discovery without any assurance that the end products would be accessible to our people should a new pandemic arise."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting frameworks previously established via the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.
"This mechanism is intended to ensure that when a nation provides its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how subsequent collaboration might be designed in a way that respects the sovereignty and interests of each country."
Health Experts Response
A leading public health body expressed it acknowledged the government's concerns, but urged that talks should continue considering a large portion of the country's Aids initiatives depended on international support.
"If specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it said.
The halted deal emphasises the ongoing tensions between receiving much-needed foreign assistance and protecting national sovereignty in an increasingly interconnected world.